Company intelligence / Profile preview

Jingjing Pharmaceutical

Ningjin County, Hebei, China
Ownership
Private
Employees
~850
Development stage
Other
01

Overview

Hebei Jingjing Pharmaceutical is a leading Chinese manufacturer specializing in the production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, particularly caffeine, theophylline, and amino acids. The company is a major global supplier of methylxanthines and maintains extensive GMP-certified manufacturing facilities.

Therapeutic areas
PulmonologyOtherGastroenterology
Modalities
Small molecule
Industry
Contract Manufacturing Organization

Beyond the preview

Go deeper on Jingjing Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jingjing Pharmaceutical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call